Wordt geladen...
Lipoprotein effects of incretin analogs and dipeptidyl peptidase 4 inhibitors
Elevated post-prandial lipoprotein levels are common in patients with type 2 diabetes. Post-prandial lipoprotein alterations in type 2 diabetics are widely believed to drive inflammation and are considered a major risk factor for cardiovascular disease in diabetic patients. The incretins glucagon li...
Bewaard in:
| Gepubliceerd in: | Clin Lipidol |
|---|---|
| Hoofdauteurs: | , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
2015
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4437760/ https://ncbi.nlm.nih.gov/pubmed/26005496 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/clp.14.59 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|